Clinical trial · Interventional
Treatment of Localized Low Grade Lymphomas
Phase III Study of Treatment of Localized Lymphomas: Radiotherapy Versus Radio-Chemotherapie
NCT00536458CI-TRIAL-00000941completedPhase 3ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To compare localiezd radiotherapy to localized radiotherapy followed by 6 cycles of chemotherapy in the treatment of localiezd low grade lymphoma
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lymphoma, Low-Grade | Lymphoma | ONTOLOGY_EXACT | 0.85 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| MINI CHEP | Drug | — | UNRESOLVED |
| radiotherapy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- radiotherapy
- description
- minichep + radiotherapy
- interventionNames
- Procedure: radiotherapy
- type
- ACTIVE_COMPARATOR
- label
- B
- description
- MINI CHEP
- interventionNames
- Drug: MINI CHEP
Primary outcomes (1)
- measure
- failure free survival at 5 years
- timeFrame
- 5 years
Secondary outcomes (3)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 79 Years
Show eligibility criteria text
Inclusion Criteria: * Low grade lymphoma defined according to the Ann Arbor classification * localized Exclusion Criteria: * Subjects unable to signed informed consent * Pregnancy
References
Publications (0)
Data not yet available
No reference posted for this study.